METLIFE INC (MET)

US59156R1086 - Common Stock

85.95  +0.76 (+0.89%)

Buy % Consensus

79

ChartMill assigns a Buy % Consensus number of 79% to MET. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 92.85. This target is 8.02% above the current price.
MET was analyzed by 21 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about MET.
In the previous month the buy percentage consensus was at a similar level.
MET was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 85.9581.8193.8492.85102.90 - -4.82% 9.18% 8.02% 19.72%
Up and Down Grades
Date Firm Action Rating
2024-11-05 Wells Fargo Maintains Overweight -> Overweight
2024-10-31 Barclays Maintains Overweight -> Overweight
2024-10-10 Wells Fargo Maintains Overweight -> Overweight
2024-10-09 TD Cowen Initiate Buy
2024-10-02 Piper Sandler Maintains Overweight -> Overweight
2024-09-27 Jefferies Maintains Buy -> Buy
2024-09-04 Barclays Initiate Overweight
2024-08-19 Morgan Stanley Maintains Overweight -> Overweight
2024-08-12 Wells Fargo Maintains Overweight -> Overweight
2024-08-01 B of A Securities Maintains Buy -> Buy
2024-07-23 Citigroup Maintains Buy -> Buy
2024-07-18 Jefferies Maintains Buy -> Buy
2024-07-10 Morgan Stanley Maintains Overweight -> Overweight
2024-07-08 Keefe, Bruyette & Woods Maintains Outperform -> Outperform
2024-07-02 JP Morgan Maintains Overweight -> Overweight
2024-06-28 Jefferies Maintains Buy -> Buy
2024-05-22 Argus Research Maintains Buy -> Buy
2024-05-10 Wells Fargo Maintains Overweight -> Overweight
2024-05-07 Keefe, Bruyette & Woods Maintains Outperform -> Outperform
2024-05-06 Piper Sandler Maintains Overweight -> Overweight
2024-04-15 Morgan Stanley Maintains Overweight -> Overweight
2024-04-11 Wells Fargo Maintains Overweight -> Overweight
2024-04-10 Keefe, Bruyette & Woods Maintains Outperform -> Outperform
2024-04-05 Piper Sandler Maintains Overweight -> Overweight
2024-02-06 Wells Fargo Maintains Overweight -> Overweight
2024-02-05 UBS Maintains Buy -> Buy
2024-01-10 UBS Maintains Buy -> Buy
2024-01-09 Goldman Sachs Maintains Buy -> Buy
2024-01-08 Goldman Sachs Upgrade Neutral -> Buy
2023-12-07 Keefe, Bruyette & Woods Maintains Outperform -> Outperform